Kamada (KMDA) Income from Continuing Operations (2012 - 2026)

Kamada (KMDA) reported Income from Continuing Operations of 4132000.0 for Q1 2026, down 55.39% on a YoY basis from 9262000.0 in Q1 2025, and down 30.04% quarter-over-quarter from 5906000.0 in Q4 2025.

Kamada (KMDA) Income from Continuing Operations (2012 - 2026) Analysis & Trends

Kamada has reported Income from Continuing Operations for 15 years, with the latest figure at 4132000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations fell 55.39% year-over-year to 4132000.0; the trailing twelve-month figure through Mar 2026 stood at 18487130.0 (up 8.48% YoY), and the FY2025 full-year result was 26736000.0, up 119.04% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 4132000.0, down from 5906000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 9262000.0 in Q1 2025, with the low at 3921000.0 in Q2 2022.
  • Historically, Income from Continuing Operations has averaged 2696929.41 across 5 years, with a median of 2944000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 518.46% — and 2024, when it surged 139016.53%.
  • Kamada's Income from Continuing Operations stood at 2944000.0 in 2022, then jumped by 71.81% to 5058000.0 in 2023, then dropped by 24.71% to 3808000.0 in 2024, then jumped by 55.09% to 5906000.0 in 2025, then tumbled by 30.04% to 4132000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 4132000.0 (Q1 2026), 5906000.0 (Q4 2025), and 8445000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Kamada 504.70 -73.15 Mn 19.12 Mn 4.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.13 Mn
Dec 31, 2025 5.91 Mn
Sep 30, 2025 8.45 Mn
Jun 30, 2025 4,130.00
Mar 31, 2025 9.26 Mn
Dec 31, 2024 3.81 Mn
Sep 30, 2024 4.03 Mn
Jun 30, 2024 -58,511.00
Mar 31, 2024 2.51 Mn
Dec 31, 2023 5.06 Mn
Sep 30, 2023 3.22 Mn
Jun 30, 2023 1.84 Mn
Mar 31, 2023 -1,809.00
Dec 31, 2022 2.94 Mn
Sep 30, 2022 493,990.00
Jun 30, 2022 -3.92 Mn
Mar 31, 2022 -1.83 Mn
Dec 31, 2021 -4.66 Mn
Sep 30, 2021 -845,000.00
Jun 30, 2021 937,000.00